breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
Marginal read alignment evidence (highest frequency 20 of 61 shown, sorted by frequency from high to low) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
* | NZ_CP009273 | 1,679,006 | 0 | A | C | 58.3% | 6.9 / 10.9 | 12 | D164A (GAC→GCC) | tus | DNA replication terminus site‑binding protein |
* | NZ_CP009273 | 1,429,972 | 0 | G | A | 57.9% | 4.5 / 18.9 | 19 | intergenic (‑96/+45) | uspF/ompN | universal stress protein UspF/porin OmpN |
* | NZ_CP009273 | 2,414,916 | 0 | T | C | 57.1% | 9.4 / 15.5 | 14 | I38T (ATC→ACC) | folX | dihydroneopterin triphosphate 2'‑epimerase |
* | NZ_CP009273 | 2,414,922 | 0 | A | C | 57.1% | 4.3 / 14.3 | 14 | Y40S (TAC→TCC) | folX | dihydroneopterin triphosphate 2'‑epimerase |
* | NZ_CP009273 | 4,594,167 | 0 | C | T | 55.8% | 5.6 / 48.5 | 43 | S64F (TCT→TTT) | bglJ | DNA‑binding transcriptional activator BglJ |
* | NZ_CP009273 | 997,447 | 0 | T | G | 55.6% | 8.8 / 21.0 | 18 | V62G (GTA→GGA) | elfG | fimbrial protein |
* | NZ_CP009273 | 1,429,975 | 0 | G | A | 55.0% | 4.6 / 21.9 | 20 | intergenic (‑99/+42) | uspF/ompN | universal stress protein UspF/porin OmpN |
* | NZ_CP009273 | 1,429,978 | 0 | T | A | 55.0% | 8.8 / 28.2 | 20 | intergenic (‑102/+39) | uspF/ompN | universal stress protein UspF/porin OmpN |
* | NZ_CP009273 | 3,273,830 | 0 | A | C | 55.0% | 17.8 / 23.5 | 20 | T85T (ACA→ACC) | agaV | PTS N‑acetylgalactosamine transporter subunit IIB |
* | NZ_CP009273 | 3,175,957 | 0 | A | T | 54.2% | 13.6 / 31.6 | 24 | I17F (ATT→TTT) | zupT | zinc transporter ZupT |
* | NZ_CP009273 | 1,080,057 | 0 | T | G | 53.8% | 7.1 / 12.7 | 13 | V409G (GTG→GGG) | efeB | iron uptake transporter deferrochelatase/peroxidase subunit |
* | NZ_CP009273 | 1,407,992 | 0 | A | T | 53.8% | 5.2 / 16.9 | 13 | Y2* (TAT→TAA) *65K (TAA→AAA) | rcbA ralR | double‑strand break reduction protein RcbA type I toxin‑antitoxin system endodeoxyribonuclease toxin RalR |
* | NZ_CP009273 | 2,360,813 | 0 | C | T | 53.8% | 3.8 / 11.3 | 14 | F88F (TTC→TTT) | arnC | undecaprenyl‑phosphate 4‑deoxy‑4‑formamido‑L‑arabinose transferase |
* | NZ_CP009273 | 5,159 | 0 | G | A | 53.3% | 1.4 / 14.1 | 15 | intergenic (+139/‑75) | thrC/yaaX | threonine synthase/DUF2502 domain‑containing protein |
* | NZ_CP009273 | 4,259,543 | 0 | T | G | 52.9% | 15.7 / 18.0 | 17 | F68V (TTT→GTT) | aphA | acid phosphatase AphA |
* | NZ_CP009273 | 4,290,979 | 0 | T | G | 52.9% | 13.7 / 20.1 | 17 | T639T (ACA→ACC) | mdtO | multidrug efflux transporter permease subunit MdtO |
* | NZ_CP009273 | 2,738,448 | 0 | A | C | 52.6% | 8.9 / 21.5 | 19 | V84G (GTG→GGG) | trmD | tRNA (guanosine(37)‑N1)‑methyltransferase TrmD |
* | NZ_CP009273 | 1,819,313 | 0 | G | A | 52.4% | 3.4 / 22.9 | 21 | intergenic (‑119/+84) | ves/spy | environmental stress‑induced protein Ves/ATP‑independent periplasmic protein‑refolding chaperone Spy |
* | NZ_CP009273 | 1,819,318 | 0 | G | A | 52.4% | 7.0 / 25.7 | 21 | intergenic (‑124/+79) | ves/spy | environmental stress‑induced protein Ves/ATP‑independent periplasmic protein‑refolding chaperone Spy |
* | NZ_CP009273 | 4,292,475 | 0 | T | G | 52.0% | 64.6 / 70.6 | 50 | T141P (ACC→CCC) | mdtO | multidrug efflux transporter permease subunit MdtO |
Marginal new junction evidence (sorted from low to high skew) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
* | ? | NZ_CP009273 | = 3547436 | 36 (1.130) | 3 (0.100) | 3/160 | 2.5 | 7.9% | coding (993/2706 nt) | malT | HTH‑type transcriptional regulator MalT |
? | NZ_CP009273 | = 3547454 | 35 (1.140) | coding (1011/2706 nt) | malT | HTH‑type transcriptional regulator MalT |